During the past decade, Rame Medical Ltd conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rame Medical Ltd" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Familial Hypercholesterolemia" (2 trials), "Atopic Dermatitis" (1 trials), "Contraception" (1 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Rame Medical Ltd" in a lesser frequency.

Most popular intervention types in "Rame Medical Ltd" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "ALN-PCSSC" (1 trials), "Crisaborole Vehicle" (1 trials), "Crisaborole ointment, 2%" (1 trials), "Evolocumab" (1 trials) and "Hydrocortisone butyrate cream, 0.1%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rame Medical Ltd" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Rame Medical Ltd". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Rame Medical Ltd, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rame Medical Ltd, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".